Wearable device shown in clinical trials to solve pain 2x better than Vicodin11-50 Employees

B2B
Early Stage
Startup in initial stages
Top Investors
This company has received a significant amount of investment from top investors

Website
: Location
San Francisco: Company size
11-50 people: Total raised
$7.2M: Company type
Consumer Tecnology Medical Device: Markets
Biotechnology Life Sciences Consumer Electronics Digital Health

ENSO careers

Wearable device shown in clinical trials to solve pain 2x better than Vicodin

1.5 billion people worldwide live with chronic pain, and the best option they have are drugs like Vicodin that have terrible side effects and make people feel sick.

Enso has developed the first opioid-free, wearable device clinically proven to solve pain better than Vicodin. It works by delivering a patented electrical stimulation treatment that relaxes the muscles and calms the nerves wherever it is applied, and it's all controlled via an app on your smartphone.

Enso is being used to solve chronic and acute pain at over 100 medical centers in the US such as Stanford, Harvard and Cedars-Sinai. The device is covered by the VA Hospitals and workers compensation insurance plans and is expected to be covered by other major insurance plans by 2020.

Jobs